These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12722409)

  • 41. [Metoclopramide stimulation in patients with benign breast disease (author's transl)].
    Maggiolo C; Cáceres E; Valdés M; Pineda G
    Rev Med Chil; 1979 Aug; 107(8):733-6. PubMed ID: 545567
    [No Abstract]   [Full Text] [Related]  

  • 42. [Plasma levels of prolactin in women with dysplasia and tumors of the breast (fibroadenoma and carcinoma of the breast)].
    Iturburu Belmonte IM; Basáñez Amuchastegui A; Jiménez Jiménez E; López de Tejada Cabeza I; Goicoechea García J; Méndez Martín J
    Rev Quir Esp; 1988; 15(1):17-21. PubMed ID: 3153353
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of raloxifene on circulating prolactin and estradiol levels in premenopausal women at high risk for developing breast cancer.
    Faupel-Badger JM; Prindiville SA; Venzon D; Vonderhaar BK; Zujewski JA; Eng-Wong J
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1153-8. PubMed ID: 16775175
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of simultaneous active immunization against 17 beta-estradiol and testosterone on pituitary and ovarian activity in the rat.
    Bourtourault M; Shacoori V; Guerin J; Saiag B; Rault B
    Res Commun Chem Pathol Pharmacol; 1991 Jun; 72(3):273-84. PubMed ID: 1947433
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endocrine modifications in women with premature menopause.
    Martorana A; Vegna G; Maneschi M
    Acta Eur Fertil; 1977 Dec; 8(4):343-7. PubMed ID: 610316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Plasma-prolactin concentrations in breast cancer at various stages, in mastopathy and other malignant tumors].
    Holtkamp W; von Heyden D; Rauschecker H; Nagel GA
    Schweiz Med Wochenschr; 1983 Oct; 113(41):1513-20. PubMed ID: 6635641
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cimetidine and plasma levels of gonadotropins, prolactin and gonadal steroids in women.
    Bélisle S; Patry M; Tétreault L
    Can Med Assoc J; 1982 Jul; 127(1):29-32. PubMed ID: 6805933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women.
    Sherman BM; Chapler FK; Crickard K; Wycoff D
    J Clin Invest; 1979 Aug; 64(2):398-404. PubMed ID: 110834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hormonal changes during continuous exercise in athletic women].
    Mesaki N; Sasaki J; Shoji M; Iwasaki H; Asano K; Eda M
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):63-9. PubMed ID: 3102649
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circadian variation of serum prolactin and TSH of women in health or with mammary carcinoma, fibroadenoma or fibrocystic mastopathy.
    Tarquini B; Gheri R; Romano S; Costa A; Cagnoni M; Lee JK; Halberg F
    Int J Chronobiol; 1980; 7(2):101-15. PubMed ID: 7450919
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recurrent breast cancer treated with the antioestrogen tamoxifen: correlation between hormonal changes and clinical course.
    Willis KJ; London DR; Ward HW; Butt WR; Lynch SS; Rudd BT
    Br Med J; 1977 Feb; 1(6058):425-8. PubMed ID: 837137
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prolactin, gonadotropic hormone and estradiol secretion in the hyperprolactinemia syndrome].
    Balabolkin MI; Gerasimov GA; Gincherman LE; Chernova TO
    Sov Med; 1988; (6):17-9. PubMed ID: 3187666
    [No Abstract]   [Full Text] [Related]  

  • 53. [The vaginal smear and hormonal status].
    Gitsch E; Czerwenka K; Huber J; Spona J
    Gynakol Rundsch; 1986; 26(3):158-65. PubMed ID: 3758834
    [No Abstract]   [Full Text] [Related]  

  • 54. Evidence of a correlation between CA15.3 and prolactin serum levels after TRH administration in women with gross cystic breast disease.
    Vizoso F; Allende MT; Fueyo A; Riera L; López Otin C; Ruibal A
    Int J Biol Markers; 1991; 6(1):31-2. PubMed ID: 1906915
    [No Abstract]   [Full Text] [Related]  

  • 55. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME; Sheehan KL; Casper RF; Yen SS
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The normal breast epithelium of women with breast cancer displays an aberrant response to estradiol.
    Khan SA; Sachdeva A; Naim S; Meguid MM; Marx W; Simon H; Halverson JD; Numann PJ
    Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):867-72. PubMed ID: 10548314
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Danazol treatment of chronic cystic mastopathy: a clinical and hormonal evaluation.
    Dhont M; Delbeke L; van Eyck J; Voorhoof L
    Postgrad Med J; 1979; 55 Suppl 5():66-70. PubMed ID: 395523
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Determination of plasma prolactin in patients with breast dysplasia].
    Vázquez Albaladejo C; Ferrer S; Merle S; Sanchis V; Camps Roig J; Giménez Climent J
    Rev Esp Oncol; 1983; 30(3):323-36. PubMed ID: 6571376
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Antigonadotropic actions of prolactin. Study of 10 cases of women with hyperprolactinemia].
    Schaison G; Mowszowicz I; Cesselin E; Lagoguey M
    Nouv Presse Med; 1977 Feb; 6(6):425-8. PubMed ID: 320558
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Interaction between beta-endorphin, steroids and peptide hormones in fibrocystic lesions of the female breast].
    Schurz B
    Wien Klin Wochenschr Suppl; 1991; 187():3-26. PubMed ID: 1648846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.